Latest News

  • Alkermes to Host Conference Call to Discuss First Quarter 2017 Financial Results Read More
  • Alkermes to Present Preclinical Data on ALKS 4230 at the American Association for Cancer Research Annual Meeting Read More
  • Alkermes to Present Data on Two-Month Dosing Option Of ARISTADA® at 16th International Congress on Schizophrenia Research Read More

Investors

Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes